Related Experiment Videos
Spontaneous remission of SSRI-induced orgasm delay
E M Haberfellner1, H Rittmannsberger
1e.m.haberfellner@aon.at
Pharmacopsychiatry
|June 8, 2004
Summary
Selective serotonin reuptake inhibitor (SSRI)-induced orgasm delay often resolves within six months. Many patients experience remission or improvement, particularly with mild to moderate symptoms, suggesting natural tolerance development.
Area of Science:
- Psychiatry
- Pharmacology
- Sexual Medicine
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed antidepressants.
- Orgasm delay is a frequent and distressing side effect impacting patient adherence and quality of life.
- Natural tolerance development is a potential management strategy for SSRI-induced sexual dysfunction.
Purpose of the Study:
- To investigate the natural course of SSRI-induced orgasm delay over a 6-month period.
- To assess the rate of remission and improvement in patients experiencing this side effect.
Main Methods:
- An open-label, naturalistic study included 108 patients initiating SSRI treatment.
- Sexual dysfunction, specifically orgasm delay, was evaluated monthly via structured interviews.
Main Results:
- Clinically significant orgasm delay developed in 26 patients.
- Complete remission occurred in 30.8% of affected patients, with 15.4% reporting marked improvement.
- Severe orgasm delay at baseline predicted a lack of remission.
Conclusions:
- A substantial number of patients develop tolerance to SSRI-induced orgasm delay within 6 months.
- Mild to moderate orgasm delay shows a higher likelihood of natural resolution.
- Waiting for tolerance may be an effective strategy for managing this side effect.